Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA,
The University of Texas MD Anderson Graduate School of Biomedical Science, Houston, Texas, USA,
Oncology. 2021;99(2):124-134. doi: 10.1159/000512172. Epub 2020 Dec 22.
The future of artificial intelligence (AI) heralds unprecedented change for the field of radiation oncology. Commercial vendors and academic institutions have created AI tools for radiation oncology, but such tools have not yet been widely adopted into clinical practice. In addition, numerous discussions have prompted careful thoughts about AI's impact upon the future landscape of radiation oncology: How can we preserve innovation, creativity, and patient safety? When will AI-based tools be widely adopted into the clinic? Will the need for clinical staff be reduced? How will these devices and tools be developed and regulated?
In this work, we examine how deep learning, a rapidly emerging subset of AI, fits into the broader historical context of advancements made in radiation oncology and medical physics. In addition, we examine a representative set of deep learning-based tools that are being made available for use in external beam radiotherapy treatment planning and how these deep learning-based tools and other AI-based tools will impact members of the radiation treatment planning team. Key Messages: Compared to past transformative innovations explored in this article, such as the Monte Carlo method or intensity-modulated radiotherapy, the development and adoption of deep learning-based tools is occurring at faster rates and promises to transform practices of the radiation treatment planning team. However, accessibility to these tools will be determined by each clinic's access to the internet, web-based solutions, or high-performance computing hardware. As seen by the trends exhibited by many technologies, high dependence on new technology can result in harm should the product fail in an unexpected manner, be misused by the operator, or if the mitigation to an expected failure is not adequate. Thus, the need for developers and researchers to rigorously validate deep learning-based tools, for users to understand how to operate tools appropriately, and for professional bodies to develop guidelines for their use and maintenance is essential. Given that members of the radiation treatment planning team perform many tasks that are automatable, the use of deep learning-based tools, in combination with other automated treatment planning tools, may refocus tasks performed by the treatment planning team and may potentially reduce resource-related burdens for clinics with limited resources.
人工智能(AI)的未来为放射肿瘤学领域带来了前所未有的变革。商业供应商和学术机构已经为放射肿瘤学创建了 AI 工具,但此类工具尚未广泛应用于临床实践。此外,大量讨论促使人们仔细思考 AI 对放射肿瘤学未来格局的影响:我们如何既能保持创新、创造力和患者安全,又能使 AI 工具广泛应用于临床?基于 AI 的工具何时将被广泛应用于临床?临床工作人员的需求将会减少吗?这些设备和工具将如何开发和监管?
在这项工作中,我们研究了深度学习作为 AI 中一个迅速兴起的分支,如何融入放射肿瘤学和医学物理学中取得的更广泛的历史进展。此外,我们还研究了一组正在提供的基于深度学习的工具,这些工具可用于外束放射治疗计划,并探讨了这些基于深度学习的工具和其他基于 AI 的工具将如何影响放射治疗计划团队的成员。
与本文探讨的过去的变革性创新(如蒙特卡罗方法或强度调制放射治疗)相比,基于深度学习的工具的开发和采用速度更快,并有望改变放射治疗计划团队的实践。然而,这些工具的可及性将取决于每个诊所访问互联网、基于网络的解决方案或高性能计算硬件的能力。正如许多技术所表现出的趋势一样,对新技术的高度依赖可能会导致产品以意外的方式出现故障、操作员错误使用或对预期故障的缓解措施不足而造成伤害。因此,开发人员和研究人员需要严格验证基于深度学习的工具,用户需要了解如何正确操作工具,专业机构需要制定使用和维护指南,这些都是至关重要的。鉴于放射治疗计划团队的成员执行许多可自动化的任务,基于深度学习的工具与其他自动化治疗计划工具结合使用,可能会重新聚焦治疗计划团队执行的任务,并可能减轻资源有限的诊所的资源相关负担。